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Nicotine regulates activity of lateral 
habenula neurons via presynaptic 
and postsynaptic mechanisms
Wanhong Zuo1, Cheng Xiao1, Ming Gao2, F. Woodward Hopf3, Krešimir Krnjević4, 
J. Michael McIntosh5, Rao Fu1, Jie Wu2, Alex Bekker1 & Jiang-Hong Ye1
There is much interest in brain regions that drive nicotine intake in smokers. Interestingly, both the 
rewarding and aversive effects of nicotine are probably critical for sustaining nicotine addiction. The 
medial and lateral habenular (LHb) nuclei play important roles in processing aversion, and recent work 
has focused on the critical involvement of the LHb in encoding and responding to aversive stimuli. 
Several neurotransmitter systems are implicated in nicotine’s actions, but very little is known about 
how nicotinic acetylcholine receptors (nAChRs) regulate LHb activity. Here we report in brain slices that 
activation of nAChRs depolarizes LHb cells and robustly increases firing, and also potentiates glutamate 
release in LHb. These effects were blocked by selective antagonists of α6-containing (α6*) nAChRs, and 
were absent in α6*-nAChR knockout mice. In addition, nicotine activates GABAergic inputs to LHb via 
α4β2-nAChRs, at lower concentrations but with more rapid desensitization relative to α6*-nAChRs. 
These results demonstrate the existence of diverse functional nAChR subtypes at presynaptic and 
postsynaptic sites in LHb, through which nicotine could facilitate or inhibit LHb neuronal activity and 
thus contribute to nicotine aversion or reward.
Nicotine, a major bioactive component in tobacco that drives addiction to smoking, has both strong rewarding 
and aversive effects1. Although reward has been considered important for addiction, both effects may be critical for 
promoting smoking, since nicotine aversion can promote craving for nicotine and intake in addicted individuals1,2. 
It is well-known that nicotine reinforcement involves midbrain dopaminergic relays to nucleus accumbens3, but 
the circuitry mediating aversive effects is less clear. Several lines of evidence suggest that nicotine may induce 
reward and aversion through opposite actions on the mesolimbic system4,5. In addition, recent studies of aversion 
have focused on the lateral and medial habenula (LHb and MHb)1. The MHb is known to negatively regulate 
nicotine intake and contribute to nicotine aversion1,6–8. There is also much interest in the LHb; LHb neurons are 
activated by several aversive stimuli9,10, which in turn excites GABAergic neurons in the rostromedial tegmental 
nucleus (RMTg)9 that inhibit midbrain dopaminergic neurons11,12. In this way, LHb could encode aversion to 
unpleasant stimuli13,14 as well as nicotine aversion1,15. Although the LHb is critical for both nicotine reinstate-
ment16 and nicotine related anxiety15, little is known about the mechanisms through which nicotine regulates 
LHb neuronal activity. Previous work has shown that nicotine robustly excites RMTg neurons12, perhaps indi-
rectly by stimulating the LHb.
Nicotine acts primarily through nicotinic acetylcholine receptors (nAChRs) composed of multiple subunits, 
which are present throughout the brain including in LHb17 and MHb18. Studies from transgenic mice suggest that 
many nAChR subtypes can contribute to nicotine withdrawal, reinforcement and aversion1,19,20. α 6*-containing 
nAChRs in particular are highly expressed in mesolimbic pathways and mediate nicotine-related reward21–23, 
though the relevant brain locations have not been completely identified21,24,25. Given the prominent aversive 
effects of nicotine1 and the LHb’s importance for aversion, we used a combination of electrophysiology and phar-
macology approach and α 6*-knockout mice to investigate whether different nAChRs contribute to nicotine mod-
ulation of LHb neuronal activity.
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Results
Nicotine excites LHb neurons. As reported previously26,27, there is a clear border between the LHb and 
the adjacent MHb (Figs 1A1 and 2). We thus distinguished the MHb and LHb neurons according to the clear 
border. In addition, consistent with previous reports, we observed that LHb neurons were loosely dispersed26, had 
heterogeneous morphological but similar membrane properties27, and were capable of producing burst firing26,28.
In the current study, we recorded from ~750 LHb neurons. Nicotine increased firing in both cell-attached 
(Fig. 1B–D) and whole-cell modes (Fig. 1F). Nicotine accelerated spontaneous firing of 77/95 LHb neurons in 
a dose-dependent manner, with an EC50 of 610 nM (F6,87 = 15.2, p < 0.001), and reached the plateau at 10 μ M 
(Fig. 1B–E). Interestingly, upon bath application of 100 nM nicotine, firing first decreased (to 90.4 ± 3.8% of base-
line, p < 0.05; Fig. 1D), then sharply accelerated (p < 0.001), returning to baseline level after washout (Fig. 1B–D). 
To confirm that the site of nicotine action was within the LHb, recordings in a subset of experiments were made from 
slices with MHb removed (Fig. 1A3). Nicotine acceleration of LHb neuron firings in these slices (F2,24= 19.9, p < 0.001; 
post hoc p < 0.001, Fig. 1E blue triangle) was similar to that with MHb (p > 0.5 with MHb vs without MHb).
In agreement with nicotine enhancement of firing, in the presence of tetrodotoxin (TTX), nicotine also 
dose-dependently depolarized LHb neurons under current-clamp mode (Fig. 1F–H), with an EC50 of 410 
nM (F6,37 = 8.2, p < 0.001; Fig. 1H). Similarly, nicotine induced inward currents (Fig. 1I) in 68/81 neurons 
under voltage-clamp at − 70 mV (in presence of blockers of sodium channels, GABAA, glycine, NMDA- and 
AMPA-type-glutamate receptors) which were dose-dependent (F6,73 = 27.5, p < 0.001; Fig. 1J) with an EC50 of 
350 nM. Thus, nicotine depolarized LHb neurons and increased their firing.
To identify nAChR subtypes that mediated nicotinic excitation of LHb neurons, we examined the effects 
of several nicotine antagonists on nicotine-induced inward currents and on firing. Since 10 μ M nicotine pro-
duced the maximal effect on LHb neuronal activity, we compared the peak amplitude of inward currents 
induced by 10 μ M nicotine in the absence and presence of various nAChR antagonists, which were applied 
for 5–8 min before co-applying nicotine or ACh. Nicotine currents were greatly reduced (F5,82 = 6.5, p < 0.001, 
One-way ANOVA; Fig. 2A,C) by mecamylamine (MEC, 1 μ Μ , p = 0.002), a non-selective nAChR antagonist, 
α -CTx-MII (100 nM, p < 0.001), an selective α 6* and α 3β 2-nAChRs antagonist22,29, MII[H9A; L15A] (100 nM, 
p = 0.036), an α 6*-nAChR blocker30, dihydro-beta-erythroidine (DHβ E, 100 nM, p = 0.006), relatively selec-
tive for α 4β 2-nAChRs, but not methyllycaconitine (MLA, 10 nM), an α 7-nAChR antagonist (p > 0.5). Thus, 
α -CTx-MII-sensitive (α 6*- ± α 3β 2-) and DHβ E-sensitive (α 4β 2) nAChRs contributed to the nicotine-induced 
LHb depolarization (Fig. 2C). In addition, although 10 μ M nicotine is higher than occurs physiologically in 
human smokers31, this concentration of nicotine was maximal and thus useful for determining in impact of dif-
ferent nAChR antagonists on nicotine modulation of different aspects of LHb physiology.
We then examined the nAChR subtypes which mediated the nicotine enhancement of LHb firing. Nicotine 
enhancement of firing was greatly attenuated by the nAChR antagonists tested above (F5,70 = 6.2, p < 0.001; 
Fig. 2B,D). Post hoc tests revealed substantial inhibition by MEC (p < 0.001), α -CTx-MII (p < 0.001) and MII 
[H9A; L15A] (p = 0.001), while DHβ E (p = 0.034) and MLA (p = 0.049) produced a smaller inhibition. Thus, 
MII-sensitive (α 6*- ± α 3β 2)–nAChRs played a prominent role in both the nicotine-induced firing enhancement 
(Fig. 2D) and membrane depolarization, while DHβ E-sensitive (α 4β 2) and MLA-sensitive (α 7) subtypes had 
partial and dissociable effects.
Apart from direct effects on LHb neurons, bath-applied nicotine could act indirectly by stimulating cho-
linergic MHb neurons (~40% of which express α 6*-nAChR mRNA32) that project to the LHb. To minimize 
indirect effects through MHb, we locally applied ACh (30 μ Μ ) onto the somata of recorded LHb neurons by 
pressure injection from a second micropipette33. In the presence of atropine, ACh induced an inward cur-
rent (25.6 ± 7.1 pA) in 6/10 neurons tested (p = 0.005) which was significantly depressed by MII [H9A; L15A] 
(to 33.0 ± 4.0% of ACh, p = 0.016; Fig. 2E). These experiments confirmed that there was a direct, MII [H9A; 
L15A]-sensitive nAChR (likely α 6*-nAChR)-mediated depolarization of LHb cells. Indirect effects via MHb were 
also unlikely since nicotine depolarized LHb cells (Figs 1F–H and 2A–D) in the presence of TTX and glutamate 
and GABA antagonists, which would block the corresponding synaptic inputs11,34,35 from MHb neurons, and also 
because nicotine activated LHb neurons in brain slices where MHb was cut off (Fig. 1E).
Nicotine enhances synaptic potentials and currents (IPSCs and EPSCs) in LHb neurons. We 
next examined whether nicotine would alter inhibitory and excitatory post-synaptic currents (IPSCs and EPSCs, 
respectively) in LHb neurons. We first examined how nicotine affects paired-pulse transmission when two PSCs 
were evoked at a brief inter-stimulus interval (50 msec). Nicotine (10 μ Μ ) selectively enhanced the first IPSC of 
each pair (IPSC1; p < 0.05; Fig. 3A,C), thus reducing the paired-pulse ratio (PSC2/PSC1 = PPR) (p < 0.01; Fig. 3D). 
Similarly, nicotine enhanced only EPSC1 of each pair (p < 0.01; Fig. 3B–D) and reduced the EPSC-PPR (p < 0.05). 
Since decreased PPR can reflect increased transmitter release at the synapse, these results suggest that nicotine 
might potentiate synaptic transmission in LHb by increasing presynaptic release of both glutamate and GABA.
To better understand the impact of nicotine on GABA and glutamate signaling in the LHb, we then tested the 
effects of nicotine on spontaneous synaptic currents. Nicotine induced a transient shift to higher frequencies and 
larger amplitudes of spontaneous IPSCs (sIPSCs) (Fig. 3E–G), with an EC50 of 40 nM for frequency (F6,98 = 9.2, 
p < 0.001; Fig. 3N, black line) and 10 nM for amplitude (F6,98 = 3.9, p = 0.002; Fig. 3O, black line). By contrast, 
nicotine induced a slowly developing increase in spontaneous EPSC (sEPSC) frequency (Fig. 3H,I) with an EC50 
of 140 nM (F6,105 = 8.9, p < 0.001; Fig. 3N, blue line), and a small but significant increase in sEPSC amplitude 
(p < 0.001, Kolmogorov-Smirnov test; Fig. 3J) with an EC50 of 210 nM (F6,105 = 4.9, p < 0.001; Fig. 3O, blue line). 
At a holding potential of − 40 mV, sEPSCs and sIPSCs appeared as distinct inward and outward currents, and nic-
otine (1 μ Μ ) induced a transient outward current followed by a sustained inward current and increased frequency 
of sIPSCs and sEPSCs (Fig. 3K,M). Similar changes were seen under current clamp, with an initial hyperpolari-
zation followed by depolarization and increased frequency of sIPSPs and sEPSPs (Fig. 3L,M). Thus, nicotine has 
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Figure 1. Nicotine regulates LHb activity. (A) Brain atlas diagram for approximate location of MHb and LHb 
(A1). Representative images of coronal slices containing the LHb with (A2) and without MHb (A3). (B–D) Nicotine 
first slowed and then accelerated LHb firing. Red arrow: initial firing reduction; (E) Concentration-response of 
nicotine-induced % increase of firing rate, recorded in cell-attached mode, in brain slices containing both LHb 
and MHb (● ). Nicotine (1 μ M and 10 μ M) caused similar increases in firing rate of LHb neurons in brain slices 
with removed MHb (∆ ). ns = no significance, with MHb vs without MHb. Number of neurons is indicated. 
Nicotine depolarization of LHb neurons (F), even in presence of TTX (G,H). (I,J) Nicotine-induced inward 
currents at a holding potential of − 70 mV, and in the presence of Inhibitor Cocktail. *p < 0.05, **p < 0.01, 
***p < 0.001, one-way ANOVA.
www.nature.com/scientificreports/
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a biphasic action in LHb, causing a transient enhancement of ongoing GABA release and a slower but sustained 
increase in glutamate release.
We also examined the impact of nicotine on miniature synaptic currents, where spontaneous release was deter-
mined in the presence of TTX, Ca2+-free ACSF (where CaCl2 was replaced by MgCl2) or in presence of 100 μ M 
Figure 2. nAChR subtypes mediating nicotine effects in LHb. (A) Nicotine-induced inward currents were 
blocked by MEC, α -CTx-MII, MII[H9A; L15A] and DHβ E, but not MLA. (B) Nicotine-induced increases in 
firing rate was prominently reduced by MEC, and MII [H9A; L15A], and weakly but significantly reduced by 
MLA. (C,D) Summary of above data. (E) Local ACh application induced an MII [H9A; L15A]-sensitive inward 
current. *p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
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Figure 3. Nicotine enhances IPSCs and EPSCs in LHb neurons. (A,B) Nicotine action on paired evoked 
IPSCs (eIPSCs) (A) and evoked EPSCs (eEPSCs) (B). eIPSCs (recorded at VH = + 40 mV) were abolished by 
gabazine (10 μ M), a GABAA receptor antagonist; eEPSCs (at VH = − 70 mV) were abolished by DNQX (20 μ M), 
an AMPA receptor blocker. (C) Nicotine (10 μ M) enhanced the first of PSC pairs. (D) % change in amplitude 
(AMP) of first PSCs and paired pulse ratio (PPR = PSC2/PSC1). (E–J) Nicotine increased spontaneous sIPSC 
frequency and amplitude (E–G) as well as sEPSC frequency (H–J). (K,L) Simultaneous recording of sIPSC/
sIPSPs and sEPSC/sEPSPs at − 40 mV under voltage-(K) and current-clamp (L). (M) Different time course 
of nicotine action on the frequency of sIPSC/Ps and sEPSC/Ps (n = 9). (N,O) Concentration-dependence of 
increased sEPSC and sIPSC frequency (N) and amplitude (O). *p < 0.05, **p < 0.01, ***p < 0.001.
www.nature.com/scientificreports/
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cadmium chloride (CdCl2, a non-selective blocker of voltage-gated calcium channels). All of these treatments 
allow determination of the effects of nicotine on synaptic release in the absence of possible effects on presynaptic 
action potential generation (TTX) or activity-dependent effects on release (calcium-free or cadmium-containing 
media). Nicotine caused a smaller but still significant increase in the frequency of spontaneous miniature EPSCs 
(F3,77 = 5.8, p = 0.001; post hoc p = 0.004) and IPSCs (F3,66 = 10.2, p < 0.001; post hoc p < 0.001) in presence of TTX 
(Fig. 4A1,B1,C), in Ca2+-free ACSF (EPSC: p = 0.042; IPSC: p < 0.001; Fig. 4A2,B2,C) or in presence of CdCl2, 
EPSC: p = 0.014; IPSC: p = 0.005; Fig. 4A3,B3,C), when compared with the effects of nicotine on spontaneous 
release when presynaptic activity is allowed to occur. In addition, both miniature EPSC (F3,77 = 5.3, p = 0.002; 
Fig. 4D) or IPSC (F3,66 = 7.6, p < 0.001; Fig. 4D) amplitudes were significantly reduced in the presence of TTX 
(EPSC: p = 0.003; IPSC: p < 0.001) or Ca2+-free ACSF (EPSC: p = 0.046; IPSC: p = 0.018). These results are con-
sistent with both presynaptic and postsynaptic actions of nicotine at excitatory and inhibitory synapses, increas-
ing glutamatergic and GABAergic release, and that these actions depended in part on calcium channels.
We next examined the nAChR subtypes that mediate the nicotinic enhancement of spontaneous synaptic 
currents. Increased sIPSC frequency was greatly attenuated (F5,123 = 5.5, p < 0.001; Fig. 5A,C) by MEC (p < 0.001) 
and DHβ E (p < 0.001) but not α -CTx-MII (p > 0.5), MII[H9A; L15A] (p > 0.5) or MLA (p = 0.28). Antagonists 
had no effects when applied alone (data not shown). Thus, DHβ E-sensitive (α 4β 2)-nAChRs but not α 6*-nAChRs 
Figure 4. Nicotine causes a smaller but significant increase in the frequency of spontaneous EPSCs (A1–3) and 
IPSCs (B1–3) in 0.5 μ M TTX, in calcium free ACSF (extracellular Ca2+ was replaced with Mg2+), and in 100 μ M 
CdCl2 (calcium channel blocker). (C,D) % increases in sEPSC and sIPSC frequency (C) and amplitude (D) induced 
by nicotine in the absence (ACSF) and presence of TTX, or calcium free ACSF, or CdCl2. ##p < 0.01, ###p < 0.001, 
Student’s paired t-test for nicotine application vs pre-nicotine control. *p < 0.05, **p < 0.01, ***p < 0.001, One-way 
ANOVA followed by Tukey’s multiple comparison test for nicotine application vs nicotine plus TTX/calcium free 
ACSF/CdCl2.
www.nature.com/scientificreports/
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were important for mediating the nicotinic enhancement of sIPSC frequency. In contrast, the enhancement of 
sEPSC frequency was reduced (F5,132 = 7.4, p < 0.001; Fig. 5B,C) by MEC (p < 0.001), α -CTx-MII (p < 0.001), 
MII[H9A; L15A] (p = 0.001), less by MLA (p = 0.009), but not significantly by DHβ E (p = 0.125). Thus, 
MII-sensitive (α 6* ± α 3β 2)- and MLA-sensitive (α 7)-nAChRs mediated nicotine’s effects on glutamatergic inputs 
to LHb neurons, similar to what was observed for the nicotine enhancement of LHb firing (Fig. 2H).
Figure 5. nAChR subtypes mediating nicotine effects on sIPSCs and sEPSCs. (A,B) Effects of various nAChR 
blockers on nicotine-induced acceleration of sIPSCs (A) and sEPSCs (B). (C) Summary of above data. *p < 0.05, 
**p < 0.01, ***p < 0.001. (D) Proposed schematic of nAChR subtype distribution in the LHb. (E,F) Nicotine 
enhanced firing (E) and mEPSC frequency (F) recorded in brain slices from wild-type (WT) but not α 6-nAChR 
knock out (α 6 KO) mice. *p < 0.05, #p < 0.05, ##p < 0.01. (G) Summary of above data.
www.nature.com/scientificreports/
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Increased firing and mEPSC frequency by nicotine are absent in α6-nAChR knock-out. Since 
pharmacology experiments suggested that α 6*-nAChRs were critical for nicotine actions in the LHb (Fig. 2), we 
directly tested the importance of α 6-nAChRs by comparing nicotine actions on LHb neurons from wild-type 
(WT) and α 6-nAChR knock-out (α 6-KO) mice. Compared to the WT mice, LHb neurons in the α 6-KO mice 
exhibit higher basal firing rate (WT: 6.6 ± 1.4 Hz, α 6-KO: 11.8 ± 2.1 Hz; p = 0.043 WT vs KO) and basal mEPSC 
frequency (WT: 1.0 ± 0.1 Hz; α 6-KO: 2.0 ± 0.5 Hz; p = 0.045) but not basal mEPSC amplitude (WT: 12.5 ± 0.7 pA; 
α 6-KO: 12.3 ± 0.7 pA; p = 0.84). Importantly, nicotine (10 μ M) significantly increased LHb firing in WT but 
not α 6-KO mutants (p = 0.03 WT vs KO; Fig. 5E,G), and increased LHb mEPSC frequency in WT but not 
α 6-KO mutants (p = 0.004; Fig. 5F,G). These results directly demonstrate the importance of α 6*-nAChRs for the 
nicotine-induced enhancement of LHb activity. Alternatively, these results could reflect an occlusion of the ability 
of nicotine to increase firing in α 6-KO mutants which have a higher basal firing rate.
Mechanism of nicotine’s biphasic action on LHb neurons. As described in Fig. 1, upon the appli-
cation of 100 nM nicotine, LHb firing was first decreased; and then sharply accelerated, returning to baseline 
after washout (Fig. 1A–C). We proposed that the decrease of firing was mediated by nicotinic potentiation of 
GABAergic transmission, and the enhancement of firing was mediated in part by nicotinic potentiation of glu-
tamatergic transmission. To test this hypothesis, we compared the effects of 100 nM nicotine in the absence and 
presence of a GABAA receptor antagonist (20 μ M gabazine), glutamate receptor antagonists (20 μ M DNQX plus 
50 μ M AP5), or a cocktail of both GABAA and glutamate receptor blockers (gabazine + DNQX + AP5).
As shown in Table 1, nicotine-induced inhibition of firing was completely abolished (F3,28 = 7.7, p < 0.001) 
by gabazine (p = 0.042) or by the cocktail (p = 0.011), but not by DNQX + AP5 (p > 0.5). In contrast, 
nicotine-induced enhancement of firing was partly attenuated (F3,34 = 5.9, p = 0.002) by DNQX + AP5 (p = 0.013) 
or by the cocktail (p = 0.04), but not by gabazine alone (p > 0.5). Thus, the ability of nicotine to increase and 
decrease firing was mediated by nicotine enhancement of IPSCs and EPSCs, respectively, although the excitatory 
effect of nicotine also involved mechanisms other than glutamate receptors.
Discussion
Converging evidence indicates that the LHb is activated by aversive stimuli36. Nicotine can have strong aversive 
effects37, which can play an important role in promoting nicotine addiction1,2. In keeping with this, we found 
that nicotine strongly activated LHb neurons in vitro, as has been observed in vivo38; in vivo, LHb activation of 
RMTg neurons would in turn inhibit midbrain dopamine (DA) neurons and thus contribute to aversion12,39. In 
addition, we found that the actions of nicotine in LHb brain slice were mediated by distinct nAChR subtypes. 
Pharmacology and α 6*-knockout experiments suggested that α 6*-nAChRs played a prominent role in the sus-
tained enhancement of LHb firing and glutamate release, while DHβ E-sensitive nAChRs, likely reflecting α 4β 2- 
nAChRs, were important for the transient increase in GABAergic transmission. Our results show that different 
nAChR subtypes played a significant role in the regulation of LHb activity, which may contribute to both nicotine 
aversion and reward.
At different concentrations found in the blood of human smokers (25–444 nM)31, nicotine acted at diverse 
nAChR subtypes to modulate LHb activity in brain slices from rats. Low concentrations (EC50 20–50 nM) 
potentiated IPSCs via DHβ E sensitive (α 4β 2) nAChRs, leading to rapid but only brief hyperpolarization, con-
sistent with α 4β 2-nAChR’s propensity to desensitization40–42. Higher nicotine concentrations (EC50 ~200 nM) 
elicited a more sustained increase in glutamate release via MII-sensitive (α 6* ± α 3β 2)- and  MLA-sensitive 
(α 7)-containing nAChRs; pharmacology and knockout experiments combined suggest a particular role for 
α 6*-nAChRs in nicotine excitation of LHb neurons. Nicotine’s actions on synaptic transmissions depended in 
part on calcium and TTX-sensitive sodium channels. At higher concentrations (EC50 ~400 nM), nicotine directly 
depolarized LHb neurons via MII- and DHβ E-sensitive nAChRs but not by MLA-sensitive nAChRs. Similarly, 
the nicotine-induced increase in firing was sensitive to Μ Ι Ι , MLA and DHβ E. The EC50 of nicotine for enhancing 
firing (~600 nM) was about 1.5 fold greater than the EC50 of the nicotine-induced current responses. The differ-
ence between the EC50 for nicotine enhancement of firing and depolarization may reflect the presence of different 
nAChRs at presynaptic terminals versus postsynaptic neurons in LHb.
Genetic variations in the CHRNA6-CHRNB3 gene cluster increase vulnerability to tobacco smoking43–45. 
α -CTx-MII infusion into α 6*-nAChRs-expressing mesolimbic regions (midbrain and nucleus accumbens)46–48 
decreases nicotine self-administration by rats21,25. Our findings show that the LHb is another critical brain region 
for α 6*-nAChR-mediated actions for nicotine. First, global disruption of α 6-nAChRs increase basal mEPSC 
frequency as well as firing rate, indicating α 6-nAChRs is a critical regulator of LHb neuronal activity. Second, 
although the MHb also expresses many nAChRs32 and projects to LHb26, the effects we observed probably orig-
inated mainly in the LHb, since α 6*-mediated LHb currents were elicited by local applications of ACh or by 
bath applications of nicotine in the presence of TTX, and persisted when the MHb was cut away from the LHb. 
Moreover, nicotinic excitation of MHb neurons in vitro49 does not require α 6*-nAChRs8. Previous immunoreac-
tivity studies28 suggest that α 6-nAChRs are mainly expressed in the ventral inferior MHb, with little expression in 
the LHb. In the current study, using the patch-clamp electrophysiology technique, one of the most sensitive ways 
to detect functional activity of receptors, we were able to detect that nicotine modulated physiological activity of 
LHb neurons through action of nAChRs containing the α 6 subunit.
Nicotine has both negative and positive motivational effects which contribute to its abuse potential1. Here we 
demonstrate that nicotine, acting through α 6*-nAChRs, depolarizes LHb neurons and enhances glutamatergic 
signaling. Manipulating LHb activity, especially through α 6*-nAChRs, may therefore be of great value in treat-
ing nicotine addiction. In addition, we have shown that, over a wide range of concentrations (10 nM–100 μ M), 
nicotine robustly activates LHb neurons. In contrast, nicotine at < 100 nM has no significant effects on DA neu-
rons in the ventral tegmental area (VTA); only at ≥ 250 nM does nicotine increase DA neuronal firing and burst 
www.nature.com/scientificreports/
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activity50,51. Interestingly, once sufficient nicotine concentrations are reached, nicotine has a stronger effect on 
VTA-DA cells than on LHb neurons. For example, we found that nicotine at 1 μ M, a concentration within the 
range of peak blood levels in smokers, increased VTA-DA neuronal discharges by an average of 2.32 ± 0.4 (n = 7) 
fold in vitro (see also ref. 52). This is in agreement with other studies53, and was significantly greater than the 
1.52 ± 0.07 (n = 13) fold increase in firing of LHb neurons (p = 0.017, unpaired t-test). Overall, the finding that 
nicotine at low concentrations activates LHb but not DA cells indicates that the LHb is exquisitely sensitive to the 
aversive effects of nicotine.
In addition to the LHb directly encoding aversive stimuli, activation of LHb neurons may contribute to aver-
sion by inhibiting DA neurons indirectly via the RMTg54,55. Like the LHb, the RMTg is activated by aversive 
stimuli. Also, our findings that nicotine excites LHb glutamatergic neurons agree with recent studies showing 
that nicotine increases presynaptic glutamate release onto RMTg neurons12,39. Furthermore, a previous electro-
physiological study in anesthetized rats showed that systemic administration of nicotine led to VTA-DA neuron 
activation which was preceded by a short-lasting inhibition56. We speculate that this inhibition of DA neurons 
could be caused by nicotine-induced excitation of LHb neurons, which activates the RMTg to inhibit DA cells. 
Emerging data also demonstrates that activation of the LHb-to-RMTg pathway induces acute avoidance9, and 
that activation of the Hb-IPN pathway reduces nicotine intake57. The Hb and its targets may also be important 
for symptoms of nicotine withdrawal, since inhibition of nAChRs in the Hb attenuates withdrawal symptoms6. 
In agreement, chronic nicotine exposure causes a hypodopaminergic state58, which may mediate the effects of 
nicotine withdrawal. Thus, reducing Hb-mediated inhibition of VTA DA neurons could be a useful strategy to 
relieve these withdrawal symptoms. These findings indicate that the LHb likely plays a critical role in different 
aspects of nicotine addiction.
Taken together, our data suggest that different subtypes of functional nAChRs are situated both presynapti-
cally on local afferents innervating LHb neurons and postsynaptically on the somatodendritic regions of these 
neurons. By activating these receptors, nicotine likely enhance the output of LHb neurons and, in this way, con-
tribute to the aversive properties of nicotine. Thus, direct nicotine action within the LHb via the pathways we 
have identified may represent a mechanism through which nicotine-related aversion could contribute to nicotine 
addiction.
Methods
Animals. The Institutional Animal Care and Use Committee of Rutgers, Rutgers, the State University of New 
Jersey, and the Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, approved all procedures. 
All methods were performed in accordance with the relevant guidelines and regulations. Animals were housed 
under standard conditions at 22–24 °C, 50–60% humidity, and a 12 h light/dark cycle. For electrophysiological 
experiments, we used Sprague-Dawley rats (at postnatal days 20–40) and C57BL/6 (B6) mice [wild-type (WT) or 
nAChR α 6 subunit knock-out (α 6 KO) mice, at postnatal days 16–23]. As data obtained from either sex did not 
differ significantly, they were pooled.
Brain slice preparation and electrophysiology. Brain slices were prepared as described earlier59. 
Animals were anesthetised with ketamine/xylazine (80 mg/5 mg/kg i.p.) and then euthanized by decapitation. 
Coronal epithalamic slices (250 μ m) were cut in ice-cold glycerol-based artificial cerebrospinal fluid (GACSF) 
containing (in mM): 252 glycerol, 2.5 KCl, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 25 NaHCO3, 0.3 L-ascorbate, and 11 
glucose, and saturated with 95%O2/5%CO2 (carbogen). Slices were then incubated > 1-hr at 24–25 °C in carbo-
genated ACSF of similar composition as GACSF, but with 126 mM NaCl replacing glycerol. In a low Ca2+ solution, 
CaCl2 was replaced by an equivalent amount of MgCl2. The experiments were performed on slices in submerged 
in a chamber perfused with ACSF at ~33 °C, at 1.5–2 ml/min. Electrical signals were recorded using an Axon 
200B or 700A amplifier and Clampfit 10.3 (Molecular Devices, Union City, CA), filtered at 2 kHz and sampled 
at 5 kHz. Patch pipettes (6–8 MΩ ) for voltage-clamp recordings contained (in mM): 140 Cs-methanesulfonate, 5 
KCl, 2 MgCl2, 10 HEPES, 2 MgATP, 0.2 NaGTP, pH 7.2. The internal solution for current-clamp recordings was 
similar except that 140 mM K-gluconate replaced Cs-methanesulfonate. IPSCs were recorded at + 40 mV in the 
presence of AP5 (50 μ M), DNQX (20 μ M) and strychnine (1 μ M) to block NMDA, AMPA and glycine receptors. 
EPSCs were recorded at − 70 mV with strychnine (1 μ M) and gabazine (10 μ M) to block glycine and GABAA 
receptors. Miniature EPSCs were recorded in the presence of 0.5 μ M tetrodotoxin (TTX). PSCs were evoked with 
a bipolar nichrome electrode within 200 μ m from the recorded neurons, applying 100–200 μ s stimuli at 0.05 Hz. 
After obtaining an input/output curve, stimulation was set to a level eliciting 20–30% of maximal currents. 
Nicotine-induced change 
of firing rate ACSF +Gabazine
+DNQX  
+ AP5
+Gabazine  
+ DNQX +AP5
Inhibition (% of baseline) 90.4 ± 3.8 (n = 8)
101.2 ± 1.0* 
(n = 8)
86.9 ± 3.5 
(n = 8) 103.4 ± 2.5* (n = 8)
 Excitation (% of baseline) 149.8 ± 7.3 (n = 14)
155.4 ± 6.8 
(n = 8)
122.4 ± 3.5* 
(n = 8) 126.5 ± 3.9* (n = 8)
Table 1.  GABA or/and glutamate transmissions mediate nicotine–induced changes in firing of LHb 
neurons. Nicotine (100 nM)-induced inhibition of spontaneous firing was abolished by the GABAA receptor 
antagonist gabazine, while nicotine-induced acceleration of firing was partly attenuated by glutamate receptor 
antagonists DNQX+ AP5. *p < 0.05, One-way ANOVA followed by Tukey’s multiple comparison test for 
nicotine application in ACSF vs nicotine plus these blockers.
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Spontaneous firing was recorded by the loose-patch cell-attached technique, allowing long-lasting recordings 
without perturbing the cytoplasmic contents, and in whole-cell mode to measure membrane potential and input 
resistance. Currents-induced by nicotine or acetylcholine (ACh) were recorded in TTX, AP5, DNQX, gabazine, 
and strychnine. Compounds were applied by bath perfusion, except acetylcholine (30 μ M, with 0.5 μ M atropine to 
block muscarinic receptors) which was ejected by pressurized air from a micropipette placed near the recorded cell33.
Drugs. We purchased common salts and [L-1-methyl-2-(3-pyridyl) pyrrolidine] freebase (nicotine), 
6,7-dinitroquinoxaline-2,3-dione (DNQX), DL-2-amino-5-phosphono-valeric acid (AP5), strychnine, mecam-
ylamine hydrochloride, methyllycaconitine, gabazine, atropine, acetylcholine, CdCl2, TTX from Sigma (St Louis, 
MO), and dihydro-β -erythroidine hydrobromide from Santa Cruz Biotechnology (Santa Cruz, CA). α -conotoxin 
MII (α -CTx-MII) and MII [H9A; L15A] were synthesized30.
Data Analysis and Statistics. Baseline electrophysiological data were recorded for 5–10 min, before drug 
superfusion and during the washout. To calculate the percent change in EPSCs/IPSCs/firing frequency or ampli-
tude for a given cell, recordings during the initial control period were averaged and normalized to 100%. eIPSC 
and eEPSC amplitudes were calculated by averaging the peak current from six sweeps during baseline and during 
each drug application. For the measurement of inward currents induced by bath application of nicotine, traces 
were filtered at 10 Hz, and the means of 30-s baseline before nicotine application and 30 s during the maximal 
effects of nicotine were calculated and subtracted to give the magnitude of the nicotine current. The peak of 
nicotinic currents induced by puffing ACh onto neuronal somata was measured after the traces were filtered at 
500 Hz. All values given in the text and figures indicate mean ± S.E.M. Statistical significance was assessed by a 
two-tailed Student’s t test, a one-way ANOVA with a Tukey’s post hoc test for multiple group comparisons, or a 
Kolmogorov-Smirnov (K-S) test. Dose-response data were fitted to the logistic equation: y = 100xα/(xα + xoα), 
where y is the percentage change, x is the concentration of nicotine, α the slope parameter, and xo the nicotine 
concentration which induces a half-maximal change.
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